Outcome of enzyme replacement therapy for hematological and visceral manifestations in children with acid sphingomyelinase deficiency: a single center experience in upper Egypt
Abstract Background Thrombocytopenia is the most common hematologic manifestation of acid sphingomyelinase deficiency (ASMD). The introduction of enzyme replacement therapy (ERT) represents significant progress in the treatment landscape of this disorder. This study presents the largest pediatric ca...
Saved in:
| Main Authors: | Mervat A. M. Youssef, Esraa Hefzy Shaker, Nahed A M Saleh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-08-01
|
| Series: | Molecular and Cellular Pediatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40348-025-00199-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Two years of compassionate use with Olipudase-alfa in a child with neurovisceral acid sphingomyelinase deficiency
by: Federica Deodato, et al.
Published: (2025-01-01) -
Diagnosis and Treatment Challenges of Niemann – Pick Disease, Type B: Clinical Case
by: Diana V. Golygina, et al.
Published: (2025-02-01) -
Advanced strategies for detecting acid sphingomyelinase deficiency type B with attenuated phenotypes
by: Thomas Villeneuve, et al.
Published: (2025-05-01) -
Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
by: Marta Morado Arias, et al.
Published: (2025-03-01) -
Coexistence of acid sphingomyelinase deficiency type A/B and Arnold-Chiari malformation: a novel case report
by: Aelita Kamalova, et al.
Published: (2025-08-01)